1. Guerra M, Sampaio F, Brás-Silva C, Leite-Moreira AF. Left intraventricular diastolic and systolic pressure gradients. Exp Biol Med (Maywood). 2011;236:1364–72.
2. Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, et al. EXPLORER-HCM study investigators. Mavacamten for treatment of symptomatic obstructive HCM (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;396:759–69. https://doi.org/10.1016/S0140-6736(20)31792-X. Erratum in: Lancet 396:758.
3. Galderisi M, Cardim N, D'Andrea A, Bruder O, Cosyns B, Davin L, et al. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:353.
4. Cohen A, Raffoul H, Diebold B, Albo C, Chevalier B, Francillon A, et al. Obstruction dynamique intraventriculaire gauche aggravée par la nitroglycérine chez les patients hypertendus âgés avec Une hypertrophie ventriculaire gauche concentrique [dynamic LV obstruction increased by nitroglycerin in elderly patients with hypertension and concentric LV hypertrophy]. Arch Mal Coeur Vaiss. 1990;83:1155–60.
5. Page SP, Pantazis A, Elliott PM. Acute myocardial ischemia associated with latent LV outflow tract obstruction in the absence of LV hypertrophy. J Am Soc Echocardiogr. 2007;72:e1–4.